Beyond Epilepsy Control: Repurposing Antiepileptic Drugs in Central Nervous System Tumor Therapy.
A comprehensive review explores cannabidiol brain tumor antiepileptic mechanisms and suggests potential antitumor activity in CNS cancers. The analysis identifies multiple pathways through which CBD and other antiepileptic drugs might combat brain tumors…
Cannabidiol and diabetic heart disease: Mechanistic evidence and translational challenges.
New preclinical research reveals CBD's potential to address multiple pathways in diabetic heart disease, including inflammation and oxidative stress. However, the cbd diabetic heart disease preclinical evidence requires human clinical trials before any…
Cannabidiol blood metabolite levels after cannabidiol treatment are associated with broadband EEG changes and improvements in visuomotor and non-verbal cognitive abilities in boys with autism requiring higher levels of support.
A rigorous clinical trial found that CBD autism spectrum disorder clinical trial results showed measurable brain activity changes in children with high-support autism. While promising for understanding CBD's neurological effects, the study did not…
Real-world effectiveness of highly purified cannabidiol in epilepsy associated with 15q11.2-q13.1 duplication and deletion syndromes: A multicenter study.
A multicenter study of CBD treatment for genetic epilepsy syndromes found meaningful seizure reduction in 64% of patients with rare 15q genetic disorders. The research provides real-world evidence supporting cannabidiol as a viable treatment option for…
5 Ways Cannabidiol Supports Neuroprotection in Alzheimer’s
Cannabidiol Alzheimer’s neuroprotection offers promising benefits for brain health by reducing neuroinflammation and oxidative stress. This treatment supports cognitive decline prevention in Alzheimer’s disease. Discover how cannabidiol influences key…
Recent Meta-Analysis Shows CBD’s Potential in MS Treatment
A recent meta-analysis highlights the potential of cbd treatment multiple sclerosis in reducing symptom severity and disease progression. The study found consistent evidence of CBD’s immunomodulatory effects in MS models. These findings support further…
Cannabidiol (CBD): a killer for inflammatory rheumatoid arthritis synovial fibroblasts
Rheumatoid arthritis is an inflammatory disorder affecting joints, with synovial fibroblasts playing a key role. Cannabidiol anti-inflammatory rheumatoid arthritis effects include reducing pro-inflammatory molecules and triggering cell death in these…